Primary prophylaxis with the implantable cardioverter-defibrillator: the need for improved risk stratification.
Gehi
Anil
A
The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. anil.gehi@msnyuhealth.org
Haas
Donald
D
Fuster
Valentin
V
D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D006323:Heart Arrest / Q000628:therapy; D006801:Humans; D018570:Risk Assessment; D013318:Stroke Volume